A few weeks ago, we published an article that characterized Gilead (GILD) as a “Value Trap.” That article was a follow-up to an earlier article which used our work on Gilead as an example of how a solid conceptual framework could help investors make better decisions. Both of these articles were based on a 16-page valuation report on Gilead we published to our members in September, 2016.
We caught a lot of flack for the recent characterization of Gilead as a value trap, but our opinion was redeemed on February 7th, when the stock fell heavily after a disappointing earnings announcement.
In today’s article, we’ll take another look at the valuation process – the most important weapon in an investor’s arsenal – in a continuation of the Gilead example. We would invite new readers to read through each of the earlier articles as well, to get a picture of the overall process!
Investing Anecdotes are Dangerous!
What interested us in September 2016, when we made our original analysis of Gilead, was the noise among the value investing community about what a deal Gilead was because the stock was trading at such a low Price-to-Earnings (P/E) ratio (See our article Three Things You Should Know About Gilead).
Top 5 Low Price Stocks To Watch For 2019: Alexco Resource Corp(AXU)
Advisors' Opinion:- [By Stephan Byrd]
Get a free copy of the Zacks research report on Alexco Resource (AXU)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 Low Price Stocks To Watch For 2019: Vanguard Extended Market ETF (VXF)
Advisors' Opinion:- [By Max Byerly]
Vanguard Extended Market ETF (NYSEARCA:VXF) declared a quarterly dividend on Thursday, June 28th, Wall Street Journal reports. Investors of record on Friday, June 29th will be given a dividend of 0.3704 per share on Tuesday, July 3rd. This represents a $1.48 annualized dividend and a yield of 1.26%. The ex-dividend date is Thursday, June 28th. This is an increase from Vanguard Extended Market ETF’s previous quarterly dividend of $0.32.
- [By Joseph Griffin]
MML Investors Services LLC lowered its position in shares of Vanguard Extended Market ETF (NYSEARCA:VXF) by 14.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,370 shares of the company’s stock after selling 1,926 shares during the quarter. MML Investors Services LLC’s holdings in Vanguard Extended Market ETF were worth $1,268,000 as of its most recent filing with the SEC.
Top 5 Low Price Stocks To Watch For 2019: Trustmark Corporation(TRMK)
Advisors' Opinion:- [By Joseph Griffin]
Get a free copy of the Zacks research report on Trustmark (TRMK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Trustmark (NASDAQ: TRMK) and Valley National Bank (NYSE:VLY) are both mid-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.
- [By Stephan Byrd]
Rhumbline Advisers lowered its position in Trustmark Corp (NASDAQ:TRMK) by 5.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 122,924 shares of the financial services provider’s stock after selling 7,773 shares during the quarter. Rhumbline Advisers owned about 0.18% of Trustmark worth $3,830,000 at the end of the most recent quarter.
Top 5 Low Price Stocks To Watch For 2019: Shore Bancshares Inc(SHBI)
Advisors' Opinion:- [By Joseph Griffin]
LSV Asset Management increased its stake in Shore Bancshares Inc (NASDAQ:SHBI) by 134.4% during the 1st quarter, Holdings Channel reports. The firm owned 157,489 shares of the bank’s stock after acquiring an additional 90,289 shares during the period. LSV Asset Management’s holdings in Shore Bancshares were worth $2,970,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Joseph Griffin]
Media coverage about Shore Bancshares (NASDAQ:SHBI) has trended somewhat positive on Sunday, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Shore Bancshares earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 47.376414932679 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
- [By Shane Hupp]
Press coverage about Shore Bancshares (NASDAQ:SHBI) has been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Shore Bancshares earned a coverage optimism score of 0.15 on Accern’s scale. Accern also assigned news headlines about the bank an impact score of 46.3784121307224 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Top 5 Low Price Stocks To Watch For 2019: eHealth Inc.(EHTH)
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on eHealth (EHTH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin]
Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 19 percent to $19.04 as the company posted upbeat Q1 results.
SVB Financial Group (NASDAQ: SIVB) shares were also up, gaining 17 percent to $301.12 following strong quarterly results.
- [By Lisa Levin]
Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 16 percent to $18.64 as the company posted upbeat Q1 results.
Enova International, Inc. (NYSE: ENVA) shares were also up, gaining 25 percent to $28.35 following Q1 results.
- [By Logan Wallace]
Los Angeles Capital Management & Equity Research Inc. boosted its stake in eHealth, Inc. (NASDAQ:EHTH) by 61.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,655 shares of the financial services provider’s stock after acquiring an additional 8,630 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned about 0.12% of eHealth worth $501,000 as of its most recent SEC filing.
- [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8. Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica. DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance. eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results. Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results. SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results. Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results. Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday. ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday. Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
- [By Ethan Ryder]
BidaskClub upgraded shares of eHealth (NASDAQ:EHTH) from a buy rating to a strong-buy rating in a research note published on Friday morning.
A number of other research firms have also recently issued reports on EHTH. ValuEngine raised shares of eHealth from a sell rating to a hold rating in a research note on Wednesday, May 2nd. Cantor Fitzgerald lifted their price target on shares of eHealth to $22.00 and gave the company an overweight rating in a research note on Friday, May 18th. Zacks Investment Research cut shares of eHealth from a buy rating to a hold rating in a research note on Tuesday, May 15th. Finally, TheStreet raised shares of eHealth from a d rating to a c- rating in a research note on Thursday, April 26th. Three research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $24.00.
No comments:
Post a Comment